Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.05. | ProstaLund AB: ProstaLund AB - Interim report January-March 2025 | 68 | GlobeNewswire (Europe) | Januari 1 - March 31Net sales reached SEK 3,7 million (3,5)Operating result amounted to -5,0 MSEK (-4,7)Profit after tax amounted to -5,0 MSEK (-4,8)Earnings per share before and after dilution amounted... ► Artikel lesen | |
PROSTALUND Aktie jetzt für 0€ handeln | |||||
23.05. | XFRA 7PL0: WIEDERAUFNAHME/RESUMPTION | 301 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
23.05. | The observation status for ProstaLund AB is updated | 171 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen | |
21.05. | Lift of Suspension in ProstaLund AB at FNSE | 138 | GlobeNewswire | 2025-05-21T15:00:36Z
Lifting of Suspension
At Trading Venue FNSE
Ended on:
2025-05-21T14:50:00Z
Ongoing: False
Comments: Nasdaq Stockholm has, to the
extent applicable, also decided to lift the suspension... ► Artikel lesen | |
20.05. | ProstaLund AB: First patients treated with CoreTherm Eagle | 154 | GlobeNewswire (Europe) | The first patients with benign prostatic hyperplasia have been successfully treated using our new CoreTherm® Eagle platform.
"We are very pleased that the first patients have been successfully treated... ► Artikel lesen | |
19.05. | XFRA 7PL0: AUSSETZUNG/SUSPENSION | 109 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROSTALUND AB 7PL0... ► Artikel lesen | |
19.05. | Suspension of Trading in ProstaLund AB at FNSE | 146 | GlobeNewswire | 2025-05-19T07:01:39Z
Suspension
At Trading Venue FNSE
Due to Other
Ongoing:
True
Comments: Nasdaq Stockholm has, to the extent applicable, also decided to
suspend the trading in all other instruments... ► Artikel lesen | |
20.02. | ProstaLund AB: ProstaLund AB - Year-end report 2024 | 100 | GlobeNewswire (Europe) | "With several ongoing contract discussions for CoreTherm® Eagle, we are positive about the interest in our treatment and the upcoming international launch"
Fourth quarterOctober 1 - December 31Net sales... ► Artikel lesen | |
14.02. | ProstaLund AB: New study confirms the strong efficacy of CoreTherm in patients with large prostates | 193 | GlobeNewswire (Europe) | A newly published Danish study has evaluated the efficacy and safety of CoreTherm® in men with prostate sizes exceeding 100 grams. The median prostate size among participants was 126 g (range: 101-230... ► Artikel lesen | |
23.12.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.12.2024 | 475 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.12.2024
Aktien
1 US67090S1087 Nuveen Churchill Direct... ► Artikel lesen | |
20.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.12.2024 | 430 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.12.2024ISIN NameBMG1961Q3325 CATCO... ► Artikel lesen | |
20.12.24 | XFRA ISIN CHANGE | 335 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenSE0002372318 ProstaLund AB 20.12.2024 SE0023468418 ProstaLund AB 23.12.2024 Tausch 40:1 ► Artikel lesen | |
20.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.12.2024 | 443 | Xetra Newsboard | Das Instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 20.12.2024 und ex Kapitalmassnahme am 23.12.2024 The instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY is traded... ► Artikel lesen | |
18.12.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for ProstaLund AB | 186 | GlobeNewswire | Referring to the press release from ProstaLund AB's from December 17, the company will carry out a reverse stock split in relations 1:40. The share will be traded under new ISIN code with effect... ► Artikel lesen | |
07.11.24 | ProstaLund AB: Interim report January-September 2024 | 135 | GlobeNewswire (Europe) | "With the first ten CoreTherm® Eagle machines manufactured, we see great opportunities to provide more clinics, both in the Nordic region and internationally, with the possibility to offer an effective... ► Artikel lesen | |
19.08.24 | ProstaLund AB: ProstaLund AB - Interim report January-June 2024 | 123 | GlobeNewswire (Europe) | ProstaLund is on a good track to establish CoreTherm® internationally again
Second quarterApril 1 - June 30Net sales reached SEK 2,8 (5,3) millionOperating profit/loss totaled SEK -7,2 million (-4,0)... ► Artikel lesen | |
24.07.24 | Nasdaq Stockholm AB: New equity right for trading, ProstaLund AB TO 3 | 406 | GlobeNewswire | At the request of ProstaLund AB, equity rights will be traded on Nasdaq First
North Growth Market as from July 25, 2024.
Security name: ProstaLund TO 3
-------------------------------
Short... ► Artikel lesen | |
18.07.24 | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of ProstaLund AB (publ) | 381 | GlobeNewswire | At the request of ProstaLund AB (publ), the last trading day in ProstaLund AB
(publ)'s paid subscription units will be changed from 2024-07-26 to 2024-07-19.
Instrument: Paid subscription units... ► Artikel lesen | |
11.07.24 | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of ProstaLund AB (publ) | 408 | GlobeNewswire | At the request of ProstaLund AB (publ), the last trading day in ProstaLund AB
(publ)'s paid subscription units will be changed from 2024-07-12 to 2024-07-26.
Instrument: Paid subscription units... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GENEDX | 88,94 | -2,16 % | GeneDx price target raised to $105 from $80 at Jefferies on AAP update | ||
GLUCOTRACK | 7,840 | 0,00 % | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | ||
SIEMENS HEALTHINEERS | 47,090 | +0,26 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Neutral" belassen. Die Bayern gehörten im europäischen Medtech-Bereich... ► Artikel lesen | |
LIFEMD | 12,830 | 0,00 % | LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend | ||
BRIGHTSPRING HEALTH SERVICES | 22,600 | -1,27 % | BTSG Raises 2025 Financial Outlook: What's Backing It? | ||
PLUS THERAPEUTICS | 0,325 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer | Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 21,740 | -1,23 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
GOODRX | 4,905 | -3,25 % | KeyBanc Maintains Overweight Rating on GoodRx (GDRX) | ||
MIMEDX | 5,960 | +0,08 % | Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock | ||
ALIGNMENT HEALTHCARE | 13,695 | -2,73 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
SEASTAR MEDICAL | 0,450 | 0,00 % | SeaStar Medical Reports Update on Nasdaq Listing Status | DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing... ► Artikel lesen | |
FRESENIUS | 42,070 | +0,29 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 49 Euro auf "Buy" belassen. Die Hessen gehörten im europäischen Medtech-Bereich zu den... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 58,19 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
BIOSIG TECHNOLOGIES | 8,100 | 0,00 % | BioSig Technologies, Inc.: BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer | Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "combined company"), which today acquired Streamex Exchange Corporation... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 47,660 | +0,36 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen |